Viewing nowCombinationTwin Eco Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shias Pharmaceutical Co., Ltd.

MFDS item code 201902540 · Approved 2019.04.23 · Insurance code 689000660
Treatment of essential hypertension not controlled with monotherapy
This medication is used for the treatment of essential hypertension in cases where blood pressure is not adequately controlled by amlodipine or telmisartan monotherapy. It effectively lowers blood pressure, reduces the risk of cardiovascular disease, and helps maintain stable blood pressure management.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before administering this medicine, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to this medicine may be considered as follows. - 40/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10mg. - 80/10mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10mg or this medicine 40/10mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine 40/5mg and 80/10mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. However, in patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose. (See section ‘3. Patients Requiring Caution’.) In patients aged 75 years or older, clearance of amlodipine is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication should be avoided during pregnancy, especially in the second and third trimesters, as it can pose serious risks to the fetus and newborn. Individuals with allergies to the ingredients of this medication or similar drugs, women who are pregnant or may become pregnant, nursing mothers, and patients with severe liver impairment or cholestatic disease should not use this medication. Patients with serious heart or blood pressure issues, particularly severe hypotension or in a state of shock, should also refrain from taking this medication. Patients with primary aldosteronism or certain heart valve diseases, those with impaired liver function, and patients with gastrointestinal disorders should use this medication with special caution. Patients with renal impairment or the elderly should also take this medication cautiously, monitoring blood pressure and kidney function periodically. The most common side effects of this medication are dizziness and peripheral edema, while fainting or heart-related abnormal symptoms may rarely occur. This medication should not be used during pregnancy; if pregnancy is confirmed, treatment should be stopped immediately and switched to a safe alternative. Hypotension may occur, so particularly those who are dehydrated or hyponatremic should manage their condition well before beginning treatment. Since there is a risk of increased potassium levels in the blood, caution is needed when taking potassium supplements or potassium-containing drugs concurrently. This medication can affect renal function, so patients with renal impairment should regularly have blood tests. Dizziness or drowsiness may occur while taking this medication, so caution is needed when driving or operating machinery. When taken with other medications, interactions may occur, so consult a doctor or pharmacist, especially when taking blood pressure medications, diuretics, potassium supplements, antibiotics, or analgesics. In case of overdose, hypotension, dizziness, and heart rhythm abnormalities may occur. Seek appropriate medical treatment immediately. This medication is not recommended for children or adolescents under 18 years of age, as its safety and efficacy have not been sufficiently established. Keep this medication out of reach of children and do not transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a container that prevents light and air exposure, at a temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the effectiveness of the medication.
White or off-white rectangular tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Shias Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.